Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ADALIMUMAB Cause Red cell distribution width increased? 144 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 144 reports of Red cell distribution width increased have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.0% of all adverse event reports for ADALIMUMAB.

144
Reports of Red cell distribution width increased with ADALIMUMAB
0.0%
of all ADALIMUMAB reports
6
Deaths
77
Hospitalizations

How Dangerous Is Red cell distribution width increased From ADALIMUMAB?

Of the 144 reports, 6 (4.2%) resulted in death, 77 (53.5%) required hospitalization, and 4 (2.8%) were considered life-threatening.

Is Red cell distribution width increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 144 reports have been filed with the FAERS database.

What Other Side Effects Does ADALIMUMAB Cause?

Drug ineffective (71,926) Pain (37,514) Arthralgia (35,592) Rheumatoid arthritis (29,817) Fatigue (29,420) Injection site pain (28,679) Headache (19,891) Nausea (19,299) Rash (18,690) Pain in extremity (18,319)

What Other Drugs Cause Red cell distribution width increased?

CLOZAPINE (439) METHOTREXATE (210) ALEMTUZUMAB (202) RITUXIMAB (198) PREDNISONE (178) PALBOCICLIB (171) METHYLPREDNISOLONE (123) ECULIZUMAB (110) TOCILIZUMAB (108) RUXOLITINIB (105)

Which ADALIMUMAB Alternatives Have Lower Red cell distribution width increased Risk?

ADALIMUMAB vs ADALIMUMAB-AACF ADALIMUMAB vs ADALIMUMAB-AATY ADALIMUMAB vs ADALIMUMAB-ADAZ ADALIMUMAB vs ADALIMUMAB-ADBM ADALIMUMAB vs ADALIMUMAB-AFZB

Related Pages

ADALIMUMAB Full Profile All Red cell distribution width increased Reports All Drugs Causing Red cell distribution width increased ADALIMUMAB Demographics